These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 18638016

  • 41. A QUEST begins.
    Oyama MA.
    J Vet Intern Med; 2008; 22(5):1076-8. PubMed ID: 18844829
    [No Abstract] [Full Text] [Related]

  • 42. Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease.
    Wolf J, Gerlach N, Weber K, Klima A, Wess G.
    J Vet Cardiol; 2012 Sep; 14(3):399-408. PubMed ID: 22858663
    [Abstract] [Full Text] [Related]

  • 43. DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study.
    Borgarelli M, Ferasin L, Lamb K, Bussadori C, Chiavegato D, D'Agnolo G, Migliorini F, Poggi M, Santilli RA, Guillot E, Garelli-Paar C, Toschi Corneliani R, Farina F, Zani A, Dirven M, Smets P, Guglielmini C, Oliveira P, Di Marcello M, Porciello F, Crosara S, Ciaramella P, Piantedosi D, Smith S, Vannini S, Dall'Aglio E, Savarino P, Quintavalla C, Patteson M, Silva J, Locatelli C, Baron Toaldo M.
    J Vet Cardiol; 2020 Feb; 27():34-53. PubMed ID: 32032923
    [Abstract] [Full Text] [Related]

  • 44. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs.
    Schuller S, Van Israël N, Vanbelle S, Clercx C, McEntee K.
    J Vet Pharmacol Ther; 2011 Aug; 34(4):322-31. PubMed ID: 20950346
    [Abstract] [Full Text] [Related]

  • 45. Efficacy of a mitral regurgitation severity index to predict long-term outcome in dogs with myxomatous mitral valve disease.
    Vereb M, Atkins CE, Adin D, Blondel T, Coffman M, Lee S, Guillot E, Ward JL.
    J Vet Intern Med; 2024 Aug; 38(1):51-60. PubMed ID: 37909399
    [Abstract] [Full Text] [Related]

  • 46. Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogs.
    Pirintr P, Saengklub N, Boonpala P, Hamlin RL, Kijtawornrat A.
    BMC Vet Res; 2023 Oct 12; 19(1):201. PubMed ID: 37821927
    [Abstract] [Full Text] [Related]

  • 47. Left atrial deformation and phasic function determined by two-dimensional speckle-tracking echocardiography in dogs with myxomatous mitral valve disease.
    Caivano D, Rishniw M, Birettoni F, Patata V, Giorgi ME, Porciello F.
    J Vet Cardiol; 2018 Apr 12; 20(2):102-114. PubMed ID: 29459124
    [Abstract] [Full Text] [Related]

  • 48. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
    Nakamura K, Kawamoto S, Osuga T, Morita T, Sasaki N, Morishita K, Ohta H, Takiguchi M.
    J Vet Intern Med; 2017 Mar 12; 31(2):316-325. PubMed ID: 28145607
    [Abstract] [Full Text] [Related]

  • 49. Canine degenerative myxomatous mitral valve disease: natural history, clinical presentation and therapy.
    Borgarelli M, Haggstrom J.
    Vet Clin North Am Small Anim Pract; 2010 Jul 12; 40(4):651-63. PubMed ID: 20610017
    [Abstract] [Full Text] [Related]

  • 50. Effect of pimobendan on echocardiographic values in dogs with asymptomatic mitral valve disease.
    Ouellet M, Bélanger MC, Difruscia R, Beauchamp G.
    J Vet Intern Med; 2009 Jul 12; 23(2):258-63. PubMed ID: 19143935
    [Abstract] [Full Text] [Related]

  • 51. Short-term effects of atorvastatin in normal dogs and dogs with congestive heart failure due to myxomatous mitral valve disease.
    Cunningham SM, Rush JE, Freeman LM.
    J Vet Intern Med; 2013 Jul 12; 27(4):985-9. PubMed ID: 23758137
    [Abstract] [Full Text] [Related]

  • 52. Atrial Fibrillation as a Prognostic Indicator in Medium to Large-Sized Dogs with Myxomatous Mitral Valvular Degeneration and Congestive Heart Failure.
    Jung SW, Sun W, Griffiths LG, Kittleson MD.
    J Vet Intern Med; 2016 Jul 12; 30(1):51-7. PubMed ID: 26681398
    [Abstract] [Full Text] [Related]

  • 53. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
    Reimann MJ, Møller JE, Häggström J, Markussen B, Holen AE, Falk T, Olsen LH.
    Vet J; 2014 Mar 12; 199(3):348-54. PubMed ID: 24507881
    [Abstract] [Full Text] [Related]

  • 54. Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease.
    Sarcinella F, Neves J, Maddox TW, Hodgkiss-Geere HM, Bode EF, Dukes-McEwan J.
    Open Vet J; 2020 Jan 12; 9(4):375-383. PubMed ID: 32042661
    [Abstract] [Full Text] [Related]

  • 55. Usefulness of conventional and tissue Doppler echocardiography to predict congestive heart failure in dogs with myxomatous mitral valve disease.
    Kim JH, Park HM.
    J Vet Intern Med; 2015 Jan 12; 29(1):132-40. PubMed ID: 25270196
    [Abstract] [Full Text] [Related]

  • 56. Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease.
    Hezzell MJ, Boswood A, Moonarmart W, Elliott J.
    J Vet Cardiol; 2012 Mar 12; 14(1):269-79. PubMed ID: 22366569
    [Abstract] [Full Text] [Related]

  • 57. Current use of pimobendan in canine patients with heart disease.
    Boswood A.
    Vet Clin North Am Small Anim Pract; 2010 Jul 12; 40(4):571-80. PubMed ID: 20610012
    [Abstract] [Full Text] [Related]

  • 58. Effects of Benazepril on Survival of Dogs with Chronic Kidney Disease: A Multicenter, Randomized, Blinded, Placebo-Controlled Clinical Trial.
    King JN, Font A, Rousselot JF, Ash RA, Bonfanti U, Brovida C, Crowe ID, Lanore D, Pechereau D, Seewald W, Strehlau G.
    J Vet Intern Med; 2017 Jul 12; 31(4):1113-1122. PubMed ID: 28669137
    [Abstract] [Full Text] [Related]

  • 59. Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double-blind, randomized, nonpivotal, exploratory field study.
    Schober KE, Rush JE, Luis Fuentes V, Glaus T, Summerfield NJ, Wright K, Lehmkuhl L, Wess G, Sayer MP, Loureiro J, MacGregor J, Mohren N.
    J Vet Intern Med; 2021 Mar 12; 35(2):789-800. PubMed ID: 33543810
    [Abstract] [Full Text] [Related]

  • 60. Potential prognostic indicators in dogs with advanced heart failure secondary to myxomatous mitral valve disease.
    Li CC, Chan IP, Chang CC, Hsueh T, Yang CC, Lin SL.
    Vet Rec; 2024 Jul 20; 195(2):e4393. PubMed ID: 38959211
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.